Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1617 1627 1629
This examiner grants 55% of resolved cases
Umamaheswari Ramachandran is an examiner in Art Unit 1617 within Tech Center 1600. With 1187 resolved cases, the examiner has a high volume of experience. The allowance rate is 54.6 percent, and the median time to allowance is 1128 days. These figures suggest a moderately challenging prosecution environment where just over half of the applications result in a grant in Art Unit 1617.
The interview lift is 53.8 percent. This is a very high lift, suggesting that interviews are extremely effective for this examiner. The 53.8 percent lift is nearly equal to the 54.6 percent base allowance rate, making interviews a vital part of any strategy. Practitioners should use interviews to improve the chances of allowance and navigate the 1128-day median pendency. The 1187 resolved cases provide a very strong statistical foundation for these observations, highlighting the importance of direct communication with this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17596784 | COMPOSITIONS AND METHODS TO POTENTIATE MUSCULOSKELETAL EFFECT OF ONE OR MORE ANABOLIC AMINO ACIDS | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 18780629 | METHODS FOR TREATING ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | Non-Final OA | SK BIOPHARMACEUTICALS CO., LTD. |
| 18842004 | (3S,4R)-3-AMINO-4-(DIFLUOROMETHYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS AS SELECTIVE INACTIVATORS OF ORNITHINE AMINOTRANSFERASE | Non-Final OA | Northwestern University |
| 18656920 | COMPOSITION COMPRISING TETRACYCLIC COMPOUND | Non-Final OA | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| 18787713 | COMBINATIONS COMPRISING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR USE | Non-Final OA | JANSSEN PHARMACEUTICA NV |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy